Skip to main content
Erschienen in: Rheumatology International 6/2005

01.09.2005 | Case Report

Thrombosis and priapism in a patient with Henoch-Schonlein purpura

verfasst von: Ismail Sari, Servet Akar, Mustafa Secil, Merih Birlik, Aykut Kefi, Fatos Onen, Ilhan Celebi, Nurullah Akkoc

Erschienen in: Rheumatology International | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Henoch-Schönlein purpura (HSP) belongs to the category of systemic small-vessel vasculitis. Although long-term outcome is generally good, serious complications may occur. Thrombosis and priapism have been reported only as extremely rare complications of HSP. We describe a 37-year-old man who developed recurrent thrombotic events shortly after he had been diagnosed as having HSP. Although he had additional risk factors for thrombosis, such as prothrombin G20210A mutation and use of celecoxib before the last episode, temporal relation of the thrombotic attacks to the onset of HSP suggest that the disease itself may lead to a prothrombotic state. This case is the first adult HSP patient with priapism, which probably developed secondary to thrombosis of the dorsal penile vein.
Literatur
1.
Zurück zum Zitat Rostoker G (2001) Schonlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 15:99–138PubMed Rostoker G (2001) Schonlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 15:99–138PubMed
2.
Zurück zum Zitat Saulsbury FT (1999) Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78:395–409 Saulsbury FT (1999) Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78:395–409
4.
Zurück zum Zitat Michel BA, Hunder GG, Bloch DA, Calabrese LH (1992) Hypersensitivity vasculitis and Henoch-Schonlein purpura: a comparison between the 2 disorders. J Rheumatol 19:721–728PubMed Michel BA, Hunder GG, Bloch DA, Calabrese LH (1992) Hypersensitivity vasculitis and Henoch-Schonlein purpura: a comparison between the 2 disorders. J Rheumatol 19:721–728PubMed
5.
Zurück zum Zitat Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M, Gonzalez-Gay MA (1997) Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40:859–864PubMed Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M, Gonzalez-Gay MA (1997) Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40:859–864PubMed
6.
Zurück zum Zitat Diana A, Gaze H, Laubscher B, De Meuron G, Tschantz P (2000) A case of pediatric Henoch-Schonlein purpura and thrombosis of spermatic veins. J Pediatr Surg 35:1843CrossRefPubMed Diana A, Gaze H, Laubscher B, De Meuron G, Tschantz P (2000) A case of pediatric Henoch-Schonlein purpura and thrombosis of spermatic veins. J Pediatr Surg 35:1843CrossRefPubMed
7.
Zurück zum Zitat Lind J, Mackay A, Withers SJ (2002) Henoch-Schonlein purpura and priapism. J Paediatr Child Health 38:526–527CrossRefPubMed Lind J, Mackay A, Withers SJ (2002) Henoch-Schonlein purpura and priapism. J Paediatr Child Health 38:526–527CrossRefPubMed
8.
Zurück zum Zitat Prandota J, Pankow-Prandota L, Kotecki L (2001) Impaired activation of the fibrinolytic system in children with Henoch-Schonlein purpura: beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 8:11–19CrossRefPubMed Prandota J, Pankow-Prandota L, Kotecki L (2001) Impaired activation of the fibrinolytic system in children with Henoch-Schonlein purpura: beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 8:11–19CrossRefPubMed
9.
Zurück zum Zitat Brendel-Muller K, Hahn A, Schneppenheim R, Santer R (2001) Laboratory signs of activated coagulation are common in Henoch-Schonlein purpura. Pediatr Nephrol 16:1084–1088CrossRefPubMed Brendel-Muller K, Hahn A, Schneppenheim R, Santer R (2001) Laboratory signs of activated coagulation are common in Henoch-Schonlein purpura. Pediatr Nephrol 16:1084–1088CrossRefPubMed
10.
Zurück zum Zitat Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS (2002) Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura. Arch Dis Child 86:132–133CrossRefPubMed Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS (2002) Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura. Arch Dis Child 86:132–133CrossRefPubMed
11.
Zurück zum Zitat Garber ME, Mohr BW, Calabrese LH (1993) Henoch-Schonlein purpura associated with anti-Ro (SSA) and antiphospholipid antibody syndrome. J Rheumatol 20:1964–1966PubMed Garber ME, Mohr BW, Calabrese LH (1993) Henoch-Schonlein purpura associated with anti-Ro (SSA) and antiphospholipid antibody syndrome. J Rheumatol 20:1964–1966PubMed
12.
Zurück zum Zitat Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703PubMed Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703PubMed
13.
Zurück zum Zitat Ozbek N, Atac FB, Verdi H, Kayiran SM (2003) Purpura fulminans in a child with combined heterozygous prothrombin G20210A and factor V Leiden mutations. Ann Hematol 82:118–120PubMed Ozbek N, Atac FB, Verdi H, Kayiran SM (2003) Purpura fulminans in a child with combined heterozygous prothrombin G20210A and factor V Leiden mutations. Ann Hematol 82:118–120PubMed
14.
Zurück zum Zitat Crofford LJ, Oates JC, McCune WJ, Gupta S, Kaplan MJ, Catella-Lawson F et al. (2000) Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases. Arthritis Rheum 43:1891–1896CrossRefPubMed Crofford LJ, Oates JC, McCune WJ, Gupta S, Kaplan MJ, Catella-Lawson F et al. (2000) Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases. Arthritis Rheum 43:1891–1896CrossRefPubMed
15.
Zurück zum Zitat Crofford LJ (2002) Specific cyclooxygenase-2 inhibitors: What have we learned since they came into widespread clinical use? Curr Opin Rheumatol 14:225–230CrossRefPubMed Crofford LJ (2002) Specific cyclooxygenase-2 inhibitors: What have we learned since they came into widespread clinical use? Curr Opin Rheumatol 14:225–230CrossRefPubMed
16.
Zurück zum Zitat Cleland LG, James MJ, Stamp LK, Penglis PS (2001) COX-2 inhibition and thrombotic tendency: a need for surveillance. Med J Aust 175:214–217PubMed Cleland LG, James MJ, Stamp LK, Penglis PS (2001) COX-2 inhibition and thrombotic tendency: a need for surveillance. Med J Aust 175:214–217PubMed
17.
Zurück zum Zitat Iorio A, Guercini F, Pini M (2003) Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 1:1906–1913CrossRefPubMed Iorio A, Guercini F, Pini M (2003) Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 1:1906–1913CrossRefPubMed
18.
Zurück zum Zitat Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS (2000) Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 160:3431–3436CrossRefPubMed Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS (2000) Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 160:3431–3436CrossRefPubMed
19.
Zurück zum Zitat Secil M, Arslan D, Goktay AY, Esen AA, Dicle O, Pirnar T (2001) The prediction of papaverine induced priapism by color Doppler sonography. J Urol 165:416–418CrossRefPubMed Secil M, Arslan D, Goktay AY, Esen AA, Dicle O, Pirnar T (2001) The prediction of papaverine induced priapism by color Doppler sonography. J Urol 165:416–418CrossRefPubMed
20.
Zurück zum Zitat Evans DT, Ward OE (1994) Dorsal vein thrombosis of the penis presenting to an STD clinic. Genitourin Med 70:406–409PubMed Evans DT, Ward OE (1994) Dorsal vein thrombosis of the penis presenting to an STD clinic. Genitourin Med 70:406–409PubMed
21.
Zurück zum Zitat Schmidt BA, Schwarz T, Schellong SM (2000) Spontaneous thrombosis of the deep dorsal penile vein in a patient with thrombophilia. J Urol 164:1649CrossRefPubMed Schmidt BA, Schwarz T, Schellong SM (2000) Spontaneous thrombosis of the deep dorsal penile vein in a patient with thrombophilia. J Urol 164:1649CrossRefPubMed
Metadaten
Titel
Thrombosis and priapism in a patient with Henoch-Schonlein purpura
verfasst von
Ismail Sari
Servet Akar
Mustafa Secil
Merih Birlik
Aykut Kefi
Fatos Onen
Ilhan Celebi
Nurullah Akkoc
Publikationsdatum
01.09.2005
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2005
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0532-3

Weitere Artikel der Ausgabe 6/2005

Rheumatology International 6/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.